Passage Bio, Inc. (PASG)
9.45
+0.01
(+0.11%)
USD |
NASDAQ |
Dec 19, 11:49
Passage Bio Market Cap: 29.49M for Dec. 19, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 524.20M |
| Palatin Technologies, Inc. | 18.45M |
| Theriva Biologics, Inc. | 6.438M |
| Oragenics, Inc. | 0.7036M |
| NanoViricides, Inc. | 22.14M |
Market Cap Related Metrics
| PEG Ratio | -0.0013 |
| Price to Book Value | 0.9475 |
| Price | 9.45 |
| Earnings Yield | -103.2% |
| PEGY Ratio | -0.0013 |